IGC Pharma, Inc. (IGC)

IGC Pharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for IGC Pharma stock has a target of 5.00, which predicts a 1,667.41% increase from the current stock price of 0.28.

Price Target: $5.00 (+1,667.41%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$5.00	$5.00	$5.00
Change	+1667.4%	+1667.4%	+1667.4%	+1667.4%

Analyst Ratings

According to 1 stock analyst, the rating for IGC Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	2	2	2	2	2	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $4.75 → $5	Strong Buy	Maintains	$4.75 → $5	+1,667.41%	Feb 23, 2026
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $4.5 → $4.75	Strong Buy	Maintains	$4.5 → $4.75	+1,579.04%	Dec 9, 2025
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $4.25 → $4.5	Strong Buy	Maintains	$4.25 → $4.5	+1,490.67%	Aug 26, 2025
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Reiterates $3.5	Strong Buy	Reiterates	$3.5	+1,137.19%	Mar 6, 2025
Edward Woo Ascendiant Capital	Ascendiant Capital	Strong Buy Maintains $4 → $4.25	Strong Buy	Maintains	$4 → $4.25	+1,402.30%	Feb 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.32M

Increased by 3.54%

from 1.27M

Revenue Next Year

1.52M

Increased by 15.12%

from 1.32M

EPS This Year

-0.07

from -0.09

EPS Next Year

-0.07

from -0.07

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	898.00K	397.00K	911.00K	1.35M	1.27M	1.32M	1.52M
Revenue Growth	-77.95%	-55.79%	129.47%	47.64%	-5.50%	3.54%	15.12%
EPS	-0.21	-0.30	-0.22	-0.22	-0.09	-0.07	-0.07
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.4M	1.6M
Avg	1.3M	1.5M
Low	1.3M	1.5M

Revenue Growth

Revenue Growth	2026	2027
High	7.6%	19.7%
Avg	3.5%	15.1%
Low	0.5%	11.7%

EPS Forecast

EPS	2026	2027
High	-0.08	-0.07
Avg	-0.07	-0.07
Low	-0.07	-0.06

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.